WorldPingAstraZeneca shares fall 8.9% over merger talks with US cancer drug firm
Proposed $400bn tie-up with Bristol Myers Squibb would create world’s fourth-largest drugmaker but analysts question rationale More than £17bn was wiped off the value of Britain’s biggest drugmaker, AstraZeneca, on Monday after a report that it was i…
Brief by WorldPing · Original reporting by The Guardian



